E Bork

543 total citations
17 papers, 460 citations indexed

About

E Bork is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, E Bork has authored 17 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in E Bork's work include Neuroendocrine Tumor Research Advances (8 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (4 papers). E Bork is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Lung Cancer Research Studies (6 papers) and Cancer therapeutics and mechanisms (4 papers). E Bork collaborates with scholars based in Denmark, Netherlands and Belgium. E Bork's co-authors include M Hansen, P Dombernowsky, Hansen Hh, Heine H. Hansen, Jens Benn Sørensen, Lars Damstrup, Torben Skovsgaard, Jens J. Holst, H.H. Hansen and Anders G. Pedersen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Endocrinology.

In The Last Decade

E Bork

17 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Bork Denmark 11 279 227 153 120 52 17 460
Marco Gigante Italy 10 135 0.5× 90 0.4× 78 0.5× 34 0.3× 52 1.0× 28 306
Yuji Nojima Japan 13 313 1.1× 212 0.9× 55 0.4× 32 0.3× 11 0.2× 26 506
Xiaolin Zhu China 13 151 0.5× 104 0.5× 219 1.4× 56 0.5× 110 2.1× 35 564
David H. Johnson United States 9 204 0.7× 109 0.5× 112 0.7× 23 0.2× 9 0.2× 12 497
Jan Vilsvik Norway 11 584 2.1× 375 1.7× 236 1.5× 414 3.5× 5 0.1× 22 827
Giuseppe Valmadre Italy 11 213 0.8× 106 0.5× 66 0.4× 118 1.0× 3 0.1× 19 321
Herbert Archer United States 8 123 0.4× 81 0.4× 124 0.8× 21 0.2× 18 0.3× 9 411
Ivana Nikolić Serbia 10 48 0.2× 142 0.6× 73 0.5× 74 0.6× 11 0.2× 30 476
Αναστάσιος Γκουντάκος Italy 10 219 0.8× 154 0.7× 175 1.1× 32 0.3× 13 0.3× 21 425
Satyaseelan Packianathan United States 9 100 0.4× 143 0.6× 57 0.4× 17 0.1× 44 0.8× 19 363

Countries citing papers authored by E Bork

Since Specialization
Citations

This map shows the geographic impact of E Bork's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Bork with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Bork more than expected).

Fields of papers citing papers by E Bork

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Bork. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Bork. The network helps show where E Bork may publish in the future.

Co-authorship network of co-authors of E Bork

This figure shows the co-authorship network connecting the top 25 collaborators of E Bork. A scholar is included among the top collaborators of E Bork based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Bork. E Bork is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Sørensen, Jakob B., Torben Skovsgaard, E Bork, Lars Damstrup, & Steen Ingeberg. (2006). Double blind, placebo-controlled randomized study of chlorhexidine prophylaxis for chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy). Journal of Clinical Oncology. 24(18_suppl). 8508–8508. 3 indexed citations
3.
4.
Schifter, Søren, Lis Johannsen, Clareann H. Bunker, et al.. (1993). Calcitonin gene‐related peptide in small cell lung carcinomas. Clinical Endocrinology. 39(1). 59–65. 9 indexed citations
5.
Bork, E, Jens Ersbøll, P Dombernowsky, et al.. (1991). Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.. Journal of Clinical Oncology. 9(9). 1627–1631. 42 indexed citations
6.
Holst, Jens J., M Hansen, E Bork, & Thue W. Schwartz. (1989). Elevated plasma concentrations of C-flanking gastrin-releasing peptide in small-cell lung cancer.. Journal of Clinical Oncology. 7(12). 1831–1838. 31 indexed citations
7.
Bork, E, Samuel A. Vest, & H.H. Hansen. (1989). A phase I clinical and pharmacokinetic study of brequinar sodium, DUP 785 (NSC 368390), using a weekly and a biweekly schedule. European Journal of Cancer and Clinical Oncology. 25(10). 1403–1411. 22 indexed citations
8.
Schwartsmann, Gilberto, E Bork, J. B. Vermorken, et al.. (1989). Mucocutaneous side effects of brequinar sodium. A new inhibitor of pyrimidine de novo biosynthesis. Cancer. 63(2). 243–248. 7 indexed citations
9.
Bork, E, et al.. (1988). A phase I evaluation of N10-propargyl-5,8-dideazafolic acid. PubMed. 24(2). 201–204. 17 indexed citations
10.
Bork, E, Mogens Hansen, Petter Urdal, et al.. (1988). Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide. European Journal of Cancer and Clinical Oncology. 24(6). 1033–1038. 39 indexed citations
11.
Vibe-Petersen, Jette, et al.. (1987). A phase I clinical evaluation of 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosourea (TCNU). European Journal of Cancer and Clinical Oncology. 23(12). 1837–1843. 14 indexed citations
12.
Sørensen, Jens Benn, H.H. Hansen, P Dombernowsky, et al.. (1987). Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs.. Journal of Clinical Oncology. 5(8). 1169–1177. 38 indexed citations
13.
Bork, E & M Hansen. (1986). Severe hyponatremia following simultaneous administration of aminoglutethimide and diuretics.. PubMed. 70(5). 689–90. 1 indexed citations
14.
Bork, E, M Hansen, P Dombernowsky, et al.. (1986). Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.. Journal of Clinical Oncology. 4(4). 524–527. 66 indexed citations
15.
Bork, E, et al.. (1985). Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma.. PubMed. 69(12). 1431–2. 67 indexed citations
16.
Hansen, M & E Bork. (1985). Peptide Hormones in Patients with Lung Cancer. Recent results in cancer research. 99. 180–186. 8 indexed citations
17.
Bork, E, et al.. (1984). Phase II study of teniposide in small cell carcinoma of the lung.. PubMed. 68(10). 1289–91. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Gigante Breakdown of academic impact, for papers by Yuji Nojima Breakdown of academic impact, for papers by Xiaolin Zhu Breakdown of academic impact, for papers by David H. Johnson Breakdown of academic impact, for papers by Jan Vilsvik Breakdown of academic impact, for papers by Giuseppe Valmadre Breakdown of academic impact, for papers by Herbert Archer Breakdown of academic impact, for papers by Ivana Nikolić Breakdown of academic impact, for papers by Αναστάσιος Γκουντάκος Breakdown of academic impact, for papers by Satyaseelan Packianathan
Rankless by CCL
2026